fluocinolone acetonide has been researched along with Recrudescence in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.00) | 18.7374 |
| 1990's | 2 (8.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 9 (36.00) | 24.3611 |
| 2020's | 5 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, N; Carrera, VH; Chalker, A; Denniston, AK; Joore, MA; Kleijnen, J; Noake, C; Petersohn, S; Pouwels, XGLV; Raatz, H; Riemsma, R; Shah, D; Witlox, W; Worthy, G | 1 |
| Cai, CX; Grewal, DS; Jaffe, GJ; Keenan, RT; Skalak, C | 1 |
| Bandello, F; Capone, L; Cicinelli, MV; Lattanzio, R; Rabiolo, A; Zollet, P | 1 |
| Jaffe, GJ; Pavesio, CE | 1 |
| Heinz, C; Pavesio, C | 1 |
| Foster, CS; Jaffe, GJ; Paggiarino, DA; Pavesio, CE; Riedel, GE | 1 |
| Burkholder, BM; Butler, NJ; Dunn, JP; Leung, TG; Ostheimer, TA; Thorne, JE | 1 |
| Cho, BJ; Do, DV; Goldstein, DA; Heo, JW; Nguyen, QD; Sepah, YJ | 1 |
| Kaiser, PK; Lowder, CY; Taban, M | 1 |
| Callanan, DG; Comstock, TL; Jaffe, GJ; Martin, DF; Pearson, PA | 1 |
| Nussenblatt, RB; Yeh, S | 1 |
| Bairi, K; Comstock, TL; Pavesio, C; Usner, DW; Zierhut, M | 1 |
| Herndon, LW; Jaffe, GJ; Malone, PE; Muir, KW | 1 |
| Dupps, WJ; Hayden, BC; Kaiser, PK; Lowder, CY; Nutter, B; Sharma, S; Taban, M; Ventura, AA | 1 |
| Arellano, I; Azulay-Abulafia, L; Bezerra Trindade Neto, P; Cestari, T; Hexsel, D; Machado-Pinto, J; Marques-Hassun, K; Muñoz, H; Ocampo-Candiani, J; Paliargues, F; Rego, V; Rivitti-Machado, MC; Sittart, JA; Trindade de Almeida, AR | 1 |
| Chow, J; Dayani, PN; Jaffe, GJ; Stinnett, SS | 1 |
| Ashton, P; Callanan, D; Comstock, TL; Eliott, D; Ip, M; Levy, B; Mann, ES; Morse, LS; Pearson, PA | 1 |
| Aneksuk, V; Thongprasom, K; Youngnak, P | 1 |
| Callanan, D; Comstock, T; Jaffe, GJ; Levy, B; Martin, D; Pearson, PA | 1 |
| Pimlott, SJ; Walker, DM | 1 |
| Larsen, K; Tos, M | 1 |
| Floden, CH; Kurwa, AR; Samman, P; Woodbridge, P | 1 |
| Samoliński, B; Swierczyński, Z; Zawisza, E | 1 |
| Christopher, AP; Cowan, MA; Grattan, CE; Robinson, M | 1 |
| Dingsør, G; Kramer, J; Olsholt, R; Søderstrøm, T | 1 |
1 review(s) available for fluocinolone acetonide and Recrudescence
| Article | Year |
|---|---|
Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Topics: Anti-Inflammatory Agents; Cost-Benefit Analysis; Drug Implants; Fluocinolone Acetonide; Humans; Intravitreal Injections; Quality-Adjusted Life Years; Recurrence; Treatment Outcome; Uveitis | 2020 |
12 trial(s) available for fluocinolone acetonide and Recrudescence
| Article | Year |
|---|---|
Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.
Topics: Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Panuveitis; Prospective Studies; Recurrence; Time Factors; Tomography, Optical Coherence; Uveitis, Posterior; Visual Acuity | 2020 |
Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results.
Topics: Chronic Disease; Double-Blind Method; Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Intravitreal Injections; Prospective Studies; Recurrence; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Uveitis, Posterior; Visual Acuity | 2019 |
FLUOCINOLONE ACETONIDE IMPLANT FOR VOGT-KOYANAGI-HARADA DISEASE: Three-Year Outcomes of Efficacy and Safety.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome | 2016 |
Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Double-Blind Method; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Postoperative Complications; Recurrence; Treatment Outcome; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2008 |
Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.
Topics: Adolescent; Adult; Aged; Child; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Uveitis, Posterior; Visual Acuity; Vitreous Body; Young Adult | 2010 |
Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity.
Topics: Dermatologic Agents; Drug Therapy, Combination; Fluocinolone Acetonide; Humans; Hydroquinones; Melanosis; Quality of Life; Recurrence; Severity of Illness Index; Surveys and Questionnaires; Tretinoin | 2012 |
Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial.
Topics: Cataract; Diabetic Retinopathy; Double-Blind Method; Drug Implants; Female; Fluocinolone Acetonide; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Retina; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Vitreous Body | 2011 |
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cataract; Child; Double-Blind Method; Drug Implants; Female; Filtering Surgery; Fluocinolone Acetonide; Glaucoma; Glucocorticoids; Humans; Intraocular Pressure; Lens, Crystalline; Male; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Uveitis, Posterior; Visual Acuity | 2006 |
A controlled clinical trial of the efficacy of topically applied fluocinonide in the treatment of recurrent aphthous ulceration.
Topics: Administration, Topical; Adolescent; Adult; Clinical Trials as Topic; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Male; Middle Aged; Recurrence; Stomatitis, Aphthous; Time Factors | 1983 |
Comparison of the response of psoriasis, over a 6-month period, to clobetasol propionate and fluocinolone acetonide ointments.
Topics: Adolescent; Adult; Aged; Betamethasone; Child; Female; Fluocinolone Acetonide; Humans; Male; Middle Aged; Psoriasis; Recurrence | 1975 |
Double-blind comparison of a dithranol and steroid mixture with a conventional dithranol regimen for chronic psoriasis.
Topics: Adolescent; Adult; Aged; Anthralin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Fluocinonide; Humans; Male; Middle Aged; Psoriasis; Random Allocation; Recurrence | 1988 |
Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy. A randomized, double blind, parallel, placebo controlled study.
Topics: Adolescent; Aerosols; Aged; Drug Evaluation; Fluocinolone Acetonide; Humans; Male; Nasal Polyps; Postoperative Period; Recurrence | 1985 |
12 other study(ies) available for fluocinolone acetonide and Recrudescence
| Article | Year |
|---|---|
Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant.
Topics: Adult; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Panuveitis; Recurrence; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Uveitis, Intermediate; Uveitis, Posterior; Visual Acuity | 2020 |
Persistent or Recurrent Diabetic Macular Edema After Fluocinolone Acetonide 0.19 mg Implant: Risk Factors and Management.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Diabetic Retinopathy; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Vascular Endothelial Growth Factor A; Visual Acuity | 2020 |
Non-infectious uveitis affecting the posterior segment treated with fluocinolone acetonide intravitreal implant: 3-year fellow eye analysis.
Topics: Cataract; Drug Implants; Eye Infections, Bacterial; Fluocinolone Acetonide; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Recurrence; Treatment Outcome; Uveitis; Visual Acuity | 2022 |
Tattoo-associated uveitis.
Topics: Adult; Biopsy; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Male; Prognosis; Recurrence; Retrospective Studies; Skin; Tattooing; Uveitis, Anterior; Visual Acuity; Young Adult | 2014 |
Outcome of fluocinolone acetonide implant (Retisert) reimplantation for chronic noninfectious posterior uveitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cataract Extraction; Chronic Disease; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glaucoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Recurrence; Retinal Detachment; Retinal Perforations; Retreatment; Retrospective Studies; Time Factors; Treatment Outcome; Uveitis, Posterior; Visual Acuity; Vitreous Hemorrhage | 2008 |
Fluocinolone acetonide for the treatment of uveitis: weighing the balance between local and systemic immunosuppression.
Topics: Drug Implants; Fluocinolone Acetonide; Glucocorticoids; Humans; Immunosuppression Therapy; Recurrence; Uveitis, Posterior | 2008 |
Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
Topics: Adult; Aged; Chronic Disease; Combined Modality Therapy; Drug Implants; Feasibility Studies; Female; Fluocinolone Acetonide; Glaucoma; Glaucoma Drainage Implants; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Uveitis, Intermediate; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2010 |
Scleral thickness following fluocinolone acetonide implant (Retisert).
Topics: Adult; Drug Implants; Female; Fluocinolone Acetonide; Glucocorticoids; Humans; Male; Middle Aged; Recurrence; Sclera; Scleral Diseases; Treatment Outcome; Uveitis, Posterior; Visual Acuity; Vitrectomy | 2010 |
Pars plana vitrectomy, fluocinolone acetonide implantation, and silicone oil infusion for the treatment of chronic, refractory uveitic hypotony.
Topics: Adult; Aged; Chronic Disease; Combined Modality Therapy; Drug Implants; Female; Fluocinolone Acetonide; Follow-Up Studies; Glucocorticoids; Humans; Intraocular Pressure; Middle Aged; Ocular Hypotension; Recurrence; Retrospective Studies; Silicone Oils; Tonometry, Ocular; Uveitis; Visual Acuity; Vitrectomy; Vitreous Body | 2011 |
Hematologic abnormalities in recurrent oral ulceration.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Case-Control Studies; Erythrocyte Indices; Erythrocytes; Erythropoiesis; Female; Fluocinolone Acetonide; Folic Acid; Folic Acid Deficiency; Glucocorticoids; Hematocrit; Hemoglobins; Humans; Male; Middle Aged; Oral Ulcer; Recurrence; Reference Values; Risk Factors; Stomatitis, Aphthous; Time Factors; Vitamin B 12 | 2002 |
Clinical course of patients with primary nasal polyps.
Topics: Adolescent; Adult; Aerosols; Aged; Aged, 80 and over; Beclomethasone; Budesonide; Child; Combined Modality Therapy; Denmark; Female; Fluocinolone Acetonide; Follow-Up Studies; Humans; Male; Middle Aged; Nasal Polyps; Pregnenediones; Recurrence | 1994 |
Long term study of aerosol corticosteroid treatment (Syntaris) in nasal polyps.
Topics: Aerosols; Anti-Inflammatory Agents; Fluocinolone Acetonide; Humans; Nasal Polyps; Recurrence | 1992 |